Emergent BioSolutions (EBS) Treasury Stock (2012 - 2026)
Emergent BioSolutions (EBS) recorded Treasury Shares of 10.7 million in Q3 2026, up 35.4% from 7.9 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Treasury Stock (2012 - 2026) Analysis & Trends
At the end of FY2025, Emergent BioSolutions reported Treasury Shares of 8.7 million, up 55.4% from FY2024.
- Annual Treasury Shares has a five-year compound annual growth rate of 48.6% (FY2020 to FY2025).
- Across earlier years, Treasury Shares came in at 5.6 million in FY2024 (unchanged), 5.6 million in FY2023 (unchanged), 5.6 million in FY2022 (+47.4%) and 3.8 million in FY2021 (+216.7%).
- On a year-over-year basis, Treasury Shares has increased for six consecutive quarters, with growth averaging 35.3% over the last eight quarters.
- Over the past five years, the year-over-year growth in Treasury Shares ranged from 0.0% (Q2 2023) to 366.7% (Q3 2022).
- Per Business Quant, the preceding three quarters came in at 10.7 million (Q2 2026), 9.6 million (Q1 2026) and 8.7 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Stock (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 76.18 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 10.62 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 64.59 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 49.00 Mn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | - |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 115.20 Bn |
| 10 | Emergent BioSolutions | 310.37 Mn | -370.73 Mn | 29.20 Mn | 270.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 270.70 Mn |
| Jun 30, 2026 | 270.50 Mn |
| Mar 31, 2026 | 261.60 Mn |
| Dec 31, 2025 | 252.60 Mn |
| Sep 30, 2025 | 243.50 Mn |
| Jun 30, 2025 | 234.60 Mn |
| Mar 31, 2025 | 227.70 Mn |
| Dec 31, 2024 | 227.70 Mn |
| Sep 30, 2024 | 227.70 Mn |
| Jun 30, 2024 | 227.70 Mn |
| Mar 31, 2024 | 227.70 Mn |
| Dec 31, 2023 | 227.70 Mn |
| Sep 30, 2023 | 227.70 Mn |
| Jun 30, 2023 | 227.70 Mn |
| Mar 31, 2023 | 227.70 Mn |
| Dec 31, 2022 | 227.70 Mn |
| Sep 30, 2022 | 227.70 Mn |
| Jun 30, 2022 | 227.70 Mn |
| Mar 31, 2022 | 204.40 Mn |
| Dec 31, 2021 | 152.20 Mn |
API Access
Emergent BioSolutions Treasury Stock API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=treasury-shares&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "treasury-shares", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=treasury-shares&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();